ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

36,791Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 2888

$2.23M Total Retail Price of All Prescriptions

Rank: 18 out of 2888

848 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 848 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

20% of this provider’s 848 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 34,808 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
FUROSEMIDE 1,649 1,597 1 6
NAMENDA 1,419 1,400 2 34
LEVOTHYROXINE SODIUM 1,395 1,354 3 1
DONEPEZIL HCL 1,371 1,371 4 26
LISINOPRIL 1,050 987 5 3
CITALOPRAM HBR 954 928 6 24
AMLODIPINE BESYLATE 869 809 7 5
SIMVASTATIN 862 819 8 2
OMEPRAZOLE 854 826 9 7
METOPROLOL TARTRATE 850 800 10 10
POTASSIUM CHLORIDE 847 821 11 14
HYDROCODONE-ACETAMINOPHEN 755 731 S3 12 4
WARFARIN SODIUM 569 545 13 22
MELOXICAM 552 515 14 31
KLOR-CON M20 514 488 15 90
PANTOPRAZOLE SODIUM 498 476 16 33
CYMBALTA 495 495 17 44
QUETIAPINE FUMARATE 482 471 18 66
GABAPENTIN 481 470 19 13
MIRTAZAPINE 423 417 20 54
ZOLPIDEM TARTRATE 413 369 21 17
TRAZODONE HCL 401 355 22 43
ESCITALOPRAM OXALATE 394 349 23 62
SERTRALINE HCL 379 349 24 27
CARVEDILOL 369 338 25 21
CIPROFLOXACIN HCL 367 356 26 47
KLOR-CON M10 366 348 27 118
AZITHROMYCIN 319 299 28 38
RISPERIDONE 308 278 29 72
DIOVAN 306 291 30 35
NITROFURANTOIN MONO-MACRO 296 267 31 162
MEGESTROL ACETATE 290 290 R 32 140
ALENDRONATE SODIUM 282 282 33 23
CLOPIDOGREL 270 242 34 30
TRAMADOL HCL 269 250 35 16
LEVOFLOXACIN 262 245 36 57
METFORMIN HCL 254 231 37 8
NEXIUM 250 239 38 19
ADVAIR DISKUS 241 219 39 60
TAMSULOSIN HCL 239 216 40 29
PRAVASTATIN SODIUM 225 212 41 12
POLYETHYLENE GLYCOL 3350 223 220 42 93
DIVALPROEX SODIUM ER 218 210 43 185
EXELON 208 199 44 106
VESICARE 201 181 45 154
LYRICA 200 178 46 69
LOSARTAN POTASSIUM 190 190 47 18
OXYBUTYNIN CHLORIDE 184 173 48 124
HYDROCHLOROTHIAZIDE 179 174 49 15
ATORVASTATIN CALCIUM 175 167 50 9
TRIAMCINOLONE ACETONIDE 169 157 51 145
CRESTOR 168 141 52 20
METOPROLOL SUCCINATE 167 167 53 11
CLONIDINE HCL 167 163 53 39
HYDRALAZINE HCL 166 166 55 59
PLAVIX 163 145 56 40
FLUTICASONE PROPIONATE 160 148 57 32
SEROQUEL 158 153 58 143
SPIRIVA 153 145 59 79
GLYBURIDE 153 126 R 59 58
NYSTATIN 145 136 61 178
SEROQUEL XR 142 142 62 271
ATENOLOL 139 130 63 25
JANTOVEN 138 133 64 163
OXYBUTYNIN CHLORIDE ER 134 134 65 132
LANTUS 132 124 66 45
DIGOXIN 128 128 67 55
FAMOTIDINE 126 117 68 75
ISOSORBIDE MONONITRATE ER 124 116 69 51
ALLOPURINOL 123 119 70 37
PROMETHAZINE HCL 119 111 R 71 96
CELEBREX 118 107 72 89
PREDNISONE 116 116 73 42
OLANZAPINE 114 103 74 137
RANITIDINE HCL 114 92 74 56
CARBIDOPA-LEVODOPA 113 109 76 113
LEXAPRO 111 101 77 198
CLONIDINE 108 108 78 247
SYMBICORT 107 98 79 142
IBUPROFEN 105 105 80 87
GALANTAMINE HBR 104 104 81 325
SPIRONOLACTONE 97 91 82 70
LOVASTATIN 95 89 83 41
ARICEPT 95 88 83 414
LATANOPROST 93 93 85 197
DIVALPROEX SODIUM 92 92 86 100
CEPHALEXIN 92 89 86 119
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 77 88 28
VENLAFAXINE HCL ER 88 88 89 120
DETROL LA 84 84 90 192
PROAIR HFA 83 81 91 71
PAROXETINE HCL 83 81 91 84
PROPRANOLOL HCL 81 81 93 164
BACLOFEN 81 48 93 121
HYDROXYZINE HCL 77 76 R 95 174
LIDODERM 77 77 95 105
ROPINIROLE HCL 76 65 97 115
LEVETIRACETAM 74 67 98 103
AGGRENOX 73 73 99 223
FLUOXETINE HCL 70 54 100 83
METOCLOPRAMIDE HCL 70 69 100 116
LOPERAMIDE 69 65 102 417
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 57 102 88
NIFEDIPINE ER 68 68 104 76
ABILIFY 66 52 105 172
DILTIAZEM 24HR CD 65 65 106 146
FINASTERIDE 65 65 106 102
BENAZEPRIL HCL 65 65 106 77
SINGULAIR 64 62 109 85
AMIODARONE HCL 60 49 110 167
ENOXAPARIN SODIUM 58 58 111 307
TORSEMIDE 57 52 112 158
GLIMEPIRIDE 55 55 113 36
LITHIUM CARBONATE 55 24 113 426
GLIPIZIDE 54 48 115 50
AMOX TR-POTASSIUM CLAVULANATE 53 50 116 112
CYCLOBENZAPRINE HCL 53 49 R 116 68
NOVOLIN R 53 53 116 109
TOBRADEX 52 48 119 586
PRIMIDONE 52 44 119 287
BUSPIRONE HCL 51 51 121 148
CEFUROXIME 51 48 121 130
BUPROPION HCL SR 50 40 123 231
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 25, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.